» Articles » PMID: 33456121

MYXOPAPILLARY EPENDYMOMA OF THE SPINAL CORD IN ADULTS: A REPORT OF PERSONAL SERIES AND REVIEW OF LITERATURE

Overview
Journal Acta Clin Croat
Specialty General Medicine
Date 2021 Jan 18
PMID 33456121
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Myxopapillary ependymomas (MPE) of the spinal cord are slow-growing benign tumors most frequently found in adults between 30 and 50 years of age. They arise from the ependyma of the filum terminale and are located in the area of the medullary conus and cauda. The recommended treatment option is gross total resection, while patients undergoing subtotal resection usually require radiotherapy. Complete resection without capsular violation can be curative and is often accomplished by simple resection of the filum above and below the tumor mass. Nevertheless, dissemination and distant treatment failure may occur in approximately 30% of the cases. In this paper, we propose an original MPE classification, which is based upon our personal series report concerned with tumor location and its correlation with the extent of resection. We also provide literature review, discussing surgical technique, tumor recurrence rate and dissemination, and adjuvant treatment. In conclusion, our findings suggest that MPE management based on the proposed 5-type tumor classification is favorable when total surgical resection is performed in carefully selected patients. Yet, further studies on a much broader model is obligatory to confirm this.

Citing Articles

Imaging of intramedullary tumours of the spinal cord.

Sasiadek M, Romanowski C, Jackow-Nowicka J Pol J Radiol. 2025; 89():e531-e540.

PMID: 39777329 PMC: 11705043. DOI: 10.5114/pjr/192424.


Epidemiological characteristics of myxopapillary ependymoma and factors affecting overall survival: a SEER-based analysis.

Huang G, Xie Z, Li J Transl Cancer Res. 2024; 13(11):6154-6164.

PMID: 39697736 PMC: 11651771. DOI: 10.21037/tcr-24-757.


From Diagnosis to Resolution: A Case Study of Myxopapillary Ependymoma Survival.

Al-Banna M, Abughazal M, Aljanabi M, Hassan M, Abouelkheir M Cureus. 2024; 16(9):e68490.

PMID: 39364501 PMC: 11447257. DOI: 10.7759/cureus.68490.


Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational Study.

Wang C, Rooney M, Alvarez-Breckenridge C, Beckham T, Chung C, De B Cancers (Basel). 2024; 16(11).

PMID: 38893133 PMC: 11171081. DOI: 10.3390/cancers16112013.


Unusual location of myxopapillary ependymoma in the sacrum: Case report and review of the literature.

Kouhen F, Mjabbar R, Alami R, El Gouach H, Cherkaoui Jaouad M, Benslima N Radiol Case Rep. 2024; 19(4):1489-1495.

PMID: 38312753 PMC: 10835126. DOI: 10.1016/j.radcr.2023.12.010.


References
1.
Nakamura M, Ishii K, Watanabe K, Tsuji T, Matsumoto M, Toyama Y . Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina. Spine (Phila Pa 1976). 2009; 34(21):E756-60. DOI: 10.1097/BRS.0b013e3181b34d16. View

2.
Bates J, Choi G, Milano M . Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes. J Neurooncol. 2016; 129(2):251-8. DOI: 10.1007/s11060-016-2167-0. View

3.
Pesce A, Palmieri M, Armocida D, Frati A, Miscusi M, Raco A . Spinal Myxopapillary Ependymoma: The Sapienza University Experience and Comprehensive Literature Review Concerning the Clinical Course of 1602 Patients. World Neurosurg. 2019; 129:245-253. DOI: 10.1016/j.wneu.2019.05.206. View

4.
Khan N, VanLandingham M, OBrien T, Boop F, Arnautovic K . Primary Seeding of Myxopapillary Ependymoma: Different Disease in Adult Population? Case Report and Review of Literature. World Neurosurg. 2017; 99:812.e21-812.e26. DOI: 10.1016/j.wneu.2016.12.022. View

5.
Fujiwara Y, Manabe H, Izumi B, Shima T, Adachi N . Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination: a case report and literature review. Eur Spine J. 2017; 27(Suppl 3):421-425. DOI: 10.1007/s00586-017-5413-z. View